Medical Safety Huddles - a Multi-site QI Project

May 24, 2023 updated by: University Health Network, Toronto

Medical Safety Huddles - a Multi-site QI (Quality Improvement) Project

This quality improvement project will implement and evaluate the impact of physician-specific huddles, termed "medical safety huddles" on patient safety within four programs/sites at Sinai Health Systems, St. John's Rehab (Sunnybrook) and University Health Network.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

4

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G 1X5
        • Mount Sinai Hospital
      • Toronto, Ontario, Canada, M2M 2G1
        • St John's Rehab
      • Toronto, Ontario, Canada, M4M 2B5
        • Bridgepoint Active Health
    • Ontario1
      • Toronto, Ontario1, Canada, M5G2A2
        • Princess Margaret Hospital - UHN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

- Any staff physicians, residents or medical students working at the four programs/sites

Exclusion criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Medical Safety Huddles - Pre-implementation
Experimental: Medical Safety Huddles - Post-implementation
These short, virtual huddles are led by a huddle leader and occur on a weekly or once every two week basis. Each site will be adapting the Medical Safety Huddles for their context and workflow to specifically engage physicians.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events
Time Frame: 19 months
We will examine whether the huddles impact the frequency and severity of adverse events experienced by patients. We will also determine if the huddles specifically impact certain types of adverse events in terms of frequency and severity. We will also perform analysis specific for each program/site.
19 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Process measure - Attendance rate
Time Frame: 15 months
The number of physicians attending each huddle will be monitored to ensure the fidelity of implementation
15 months
Process measure - Safety issues
Time Frame: 15 months
The type and number of safety issues brought up during huddles will be monitored on a monthly basis to ensure the fidelity of implementation
15 months
Process measure - Actions taken to address safety issues
Time Frame: 15 months
The number of actions taken to address safety issues will be monitored on a monthly basis to ensure the fidelity of implementation
15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Meiqi Guo, MD, University Health Network, Toronto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2020

Primary Completion (Actual)

October 31, 2022

Study Completion (Actual)

January 30, 2023

Study Registration Dates

First Submitted

April 20, 2022

First Submitted That Met QC Criteria

May 3, 2022

First Posted (Actual)

May 9, 2022

Study Record Updates

Last Update Posted (Actual)

May 25, 2023

Last Update Submitted That Met QC Criteria

May 24, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 19-6357

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe